Venlafaxine versus imipramine in painful polyneuropathy: A randomized, controlled trial

Neurology

Volumn 60, Issue 8, 2003, Pages 1284-1289

  Sindrup, S H ^a   Bach, F W ^b   Madsen, C ^a   Gram, L F ^c   Jensen, T S ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; VENLAFAXINE;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; IMPOTENCE; MALE; MICTURITION DISORDER; NAUSEA; PAIN ASSESSMENT; POLYNEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY SYSTEM; STATISTICAL ANALYSIS; STOMACH DISEASE; SWEATING; TREATMENT OUTCOME; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0347185884     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000058749.49264.BD     Document Type: Article

References (24)

1. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55:915-920.
2. Sindrup SH. Antidepressants as analgesics. In: Yaksh et al., eds. Anaesthesiology: biological foundations. Philadelphia: Lippincott-Raven, 1997:987-997.
3. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256.
4. Sindrup SH, Gram LF, Brøsen K, Eshøj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-144.
5. Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aaes-Jørgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-552.
6. Holliday SM, Benfield P. Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs 1995;49:280-294.
7. Bolden-Watson C, Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into brain synaptosomes. Life Sci 1993;52:1023-1029.
8. Muth EA, Moyer JA, Haskin JT, et al. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986;35:4493-4497.
9. Muth EA, Moyer JA, Haskin JT, et al. Biochemical, neurophysiological and behavioral effects of WY-45,233 and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res 1991;23:191-193.
10. Lang E, Hord AH, Denson D. Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain 1996;68:151-155.
11. Schreiber S, Backer MM, Pick CG. The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 1999;273:85-88.
12. Enggaard TP, Klitgaard NA, Gram LF, Arendt-Nielsen L, Sindrup SH. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther 2001;69:245-251.
13. Brøsen K, Nielsen PN, Brusgaard K, Gram LF, Skjødt K. CYP2D6 genotype determination in the Danish population. Eur J Clin Pharmacol 1994;47:221-225.
14. Brøsen K, Otton SV, Gram LF. Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotype. Clin Pharmacol Ther 1986;40:543-549.
15. Lessard E, Yessine MA, Hamelin BA, O'Hara G, LeBlanc J, Turgeons J. Influence of CYP2D6 on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans. Pharmacogenetics 1999;9:435-443.
16. Sindrup SH, Gram LF, Skjold T, Frøland A, Beck-Nielsen H. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990;47:509-515.
17. Gottrup H, Nielsen J, Arendt-Nielsen L, Jensen TS. The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury. Pain 1999;75:321-329.
18. Nurmikko T, Bowsher D. Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 1990;53:135-141.
19. Enggaard TP, Poulsen L, Arendt-Nielsen L, et al. The analgesic effect of codeine as compared to imipramine in different human experimental pain models. Pain 2001;92:277-282.
20. Senn SJ. Cross-over trials in clinical research. New York: Wiley, 1993.
21. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen P, Moore A. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-227.
22. Kunz NR, Goli V, Entsuah AR. Venlafaxine extended release in the treatment of pain associated with diabetic neuropathy. Neurology 2000;54(suppl 3):A441. Abstract.
23. + channels by antidepressant drugs. J Pharmacol Exp Ther 1998;284:208-214.
24. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis 2001;3:53-62.